Equillium to Present at Two Upcoming Investor Conferences

LA JOLLA, Calif.--(BUSINESS WIRE)-- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders with high unmet medical need, today announced that it will participate in fireside chat presentations at the Stifel 2021 Virtual Healthcare Conference and the Jefferies Virtual London Healthcare Conference.

Management will provide a high-level overview of itolizumab’s mechanism of action and review each of Equillium’s ongoing clinical programs, as well as data recently presented at ACR, ASN & ACAAI. Members of Equillium’s leadership team will be available for one-on-one meetings during both conferences.

Webcast access for both presentations will be available on the “Events & Presentations” section of the Company’s website at https://ir.equilliumbio.com/events-and-presentations. An archived replay of both conferences will be available for 90 days.

About Equillium

Equillium is a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop novel products to treat severe autoimmune and inflammatory disorders with high unmet medical need. Equillium is developing itolizumab for multiple severe immuno-inflammatory diseases, including acute graft-versus-host-disease (aGVHD), lupus/lupus nephritis and uncontrolled asthma.

For more information, visit www.equilliumbio.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211109005733/en/

Investor Contact
Michael Moore
Vice President, Investor Relations & Corporate Communications
619-302-4431
[email protected]

Media Contacts
Aljanae Reynolds
Wheelhouse Life Science Advisors
[email protected]

Source: Equillium, Inc.

You May Also Be Interested In

• AngioDynamics Reports Record Fiscal Year 2026 Fourth Quarter and Full Year Financial Results; Continued Execution Drives Med Tech Growth and Full-Year Profitability
• Thira Raises $21 Million Seed Round Led by Madrona to Build the Back-Office That Runs Itself
• ECN Launches ABM Matcher, Bringing Account-Based Marketing to Premium Office DOOH